Literature DB >> 16444597

Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts.

Ségolène Gambert1, Catherine Vergely, Rodolphe Filomenko, Daniel Moreau, Ali Bettaieb, Lionel H Opie, Luc Rochette.   

Abstract

The mechanisms of the adverse effects of free fatty acids on the ischemic-reperfused myocardium are not fully understood. Long-chain fatty acids, including palmitate, uncouple oxidative phosphorylation and should therefore promote the formation of oxygen-derived free radicals, with consequent adverse effects. Conversely, the antianginal agent trimetazidine (TMZ), known to inhibit cardiac fatty acid oxidation, could hypothetically lessen the formation of reactive oxygen species (ROS) and thus improve reperfusion mechanical function. Isolated perfused rat hearts underwent 30 min of total global ischemia followed by 30 min of reperfusion. Hearts were perfused with glucose 5.5 mmol/l or palmitate 1.5 mmol/l with or without TMZ (100 micromol/l). Ascorbyl free radical (AFR) release during perfusion periods was measured by electron spin resonance as a marker of oxidative stress. Post-ischemic recovery in the palmitate group of heart was lower than in the glucose group with a marked rise in diastolic tension and reduction in left ventricular developed pressure (Glucose: 85 +/- 11 mmHg; Palmitate: 10 +/- 6 mmHg; p < 0.001). TMZ decreased diastolic tension in both glucose- and in palmitate-perfused hearts. Release of AFR within the first minute of reperfusion was greater in palmitate-perfused hearts and in hearts perfused with either substrate, this marker of oxidative stress was decreased by TMZ (expressed in arbitrary units/ml; respectively: 8.49 +/- 1.24 vs. 1.06 +/- 0.70 p < 0.05; 12.47 +/- 2.49 vs. 3.37 +/- 1.29 p < 0.05). Palmitate increased the formation of ROS and reperfusion contracture. TMZ, a potential inhibitor of palmitate-induced mitochondrial uncoupling, decreased the formation of free radicals and improved postischemic mechanical dysfunction. The novel conclusion is that adverse effects of fatty acids on ischemic-reperfusion injury may be mediated, at least in part, by oxygen-derived free radicals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444597     DOI: 10.1007/s11010-006-2518-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  EFFECT OF FASTING ON GLUCOSE AND PALMITATE METABOLISM OF PERFUSED RAT HEART.

Authors:  L H OPIE; J R EVANS; J C SHIPP
Journal:  Am J Physiol       Date:  1963-12

2.  Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism.

Authors:  R J BING; A SIEGEL; I UNGAR; M GILBERT
Journal:  Am J Med       Date:  1954-04       Impact factor: 4.965

3.  Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.

Authors:  Costantinos Pantos; Anne Bescond-Jacquet; Stylianos Tzeis; Ioannis Paizis; Iordanis Mourouzis; Panagiotis Moraitis; Vassiliki Malliopoulou; Eustathia D Politi; Hariklia Karageorgiou; Dennis Varonos; Dennis V Cokkinos
Journal:  Basic Res Cardiol       Date:  2004-12-23       Impact factor: 17.165

4.  Direct measurement of free radical generation in isolated rat heart by electron paramagnetic resonance spectroscopy: effect of trimetazidine.

Authors:  V Maupoil; L Rochette; A Tabard; P Clauser; C Harpey
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

5.  Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction.

Authors:  M F Oliver; V A Kurien; T W Greenwood
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

6.  Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on postischemic recovery during reperfusion.

Authors:  C Vergely; V Maupoil; M Benderitter; L Rochette
Journal:  Free Radic Biol Med       Date:  1998-02       Impact factor: 7.376

7.  The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.

Authors:  P F Kantor; A Lucien; R Kozak; G D Lopaschuk
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

8.  Blockade of electron transport during ischemia protects cardiac mitochondria.

Authors:  Edward J Lesnefsky; Qun Chen; Shadi Moghaddas; Medhat O Hassan; Bernard Tandler; Charles L Hoppel
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

Review 9.  Oxygen-derived free radicals and myocardial reperfusion injury: an overview.

Authors:  R Bolli
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

10.  An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.

Authors:  G D Lopaschuk; R B Wambolt; R L Barr
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

View more
  21 in total

1.  Prolonged pain to hospital time is associated with increased plasma advanced oxidation protein products and poor prognosis in patients with percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Yi Feng; Chengxing Shen; Genshan Ma; Jihui Wang; Zhong Chen; Qiming Dai; Hong Zhi; Chengjian Yang; Qiang Fu; Gensheng Shang; Yuanyuan Guan
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

2.  Improvement of mechanical heart function by trimetazidine in db/db mice.

Authors:  Yuan-jing Li; Pei-hua Wang; Chen Chen; Ming-hui Zou; Dao-wen Wang
Journal:  Acta Pharmacol Sin       Date:  2010-04-12       Impact factor: 6.150

3.  Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes.

Authors:  Karin Przyklenk; Michelle Maynard; Dale L Greiner; Peter Whittaker
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

4.  Competition between acetate and oleate for the formation of malonyl-CoA and mitochondrial acetyl-CoA in the perfused rat heart.

Authors:  Fang Bian; Takhar Kasumov; Kathryn A Jobbins; Paul E Minkler; Vernon E Anderson; Janos Kerner; Charles L Hoppel; Henri Brunengraber
Journal:  J Mol Cell Cardiol       Date:  2006-10-03       Impact factor: 5.000

5.  Mesenchymal stem cells preconditioned with trimetazidine promote neovascularization of hearts under hypoxia/reoxygenation injury.

Authors:  Xiaowu Hu; Junjie Yang; Ying Wang; You Zhang; Masaaki Ii; Zhenya Shen; Jie Hui
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 6.  Radionuclide imaging of myocardial metabolism.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Cardiovasc Imaging       Date:  2010-03       Impact factor: 7.792

7.  Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure.

Authors:  Elena N Dedkova; Lea K Seidlmayer; Lothar A Blatter
Journal:  J Mol Cell Cardiol       Date:  2013-02-04       Impact factor: 5.000

8.  Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression.

Authors:  Sheik Wisel; Mahmood Khan; M Lakshmi Kuppusamy; I Krishna Mohan; Simi M Chacko; Brian K Rivera; Benjamin C Sun; Kálmán Hideg; Periannan Kuppusamy
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

9.  Bax signaling regulates palmitate-mediated apoptosis in C(2)C(12) myotubes.

Authors:  Jonathan M Peterson; Yan Wang; Randall W Bryner; David L Williamson; Stephen E Alway
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-07       Impact factor: 4.310

10.  Inhibition of lipogenesis reduces inflammation and organ injury in sepsis.

Authors:  Juan Pablo Idrovo; Weng-Lang Yang; Asha Jacob; Lana Corbo; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  J Surg Res       Date:  2015-07-02       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.